+(91) 79 4891 1722



Exemestane is a drug used to treatbreast cancer. It is a member of the class of drugs known as aromataseinhibitors. Some breast cancers require estrogen to grow. Exemestane decreasesthe amount of estrogen the body makes and helps to slow or reverse the growthof these breast cancers.

Ralington pharma LLP (India), a globalmanufacturer and supplier for Exemestane, 107868-30-4 for R&D, Pilot orCommercials  Quantities withPharmacopeial Grade USP/ EP/ BP/ IP/ JP/In-House.

Exemestane, 107868-30-4 availablewith USDMF,EDMF, DMF, USFDA, EUGMP, GMP,ISO CERTIFIED,WHO-GMP and DMF as per the requirement. Product supply inStandard Packaging & labeling as per FDA along with supportivedocumentation. We can also offer Intermediates of  Exemestane, 107868-30-4.

ProductType : API
Molecular Formula : C20H24O2
CASNo : 107868-30-4
Grades : DMF,GMP,Technical Package,USP,BP,EP,IP,USDMF,EDMF,CEP/COS
Molecular Weight : 296.40
Synonym : 6-Methylenandrosta-1,4-diene-3,17-dione; 10,13-Dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-,,,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).